Efficacy of Favipiravir Against Severe Ebola Virus Disease

计划入组 77 人 · 首次发布于 2016 年 1 月 26 日

Ebola_CP

计划入组 130 人

Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea

计划入组 606 人 · 首次发布于 2015 年 1 月 19 日

Recombinant Ebola Virus Disease Vaccine(Adenovirus Type 5 Vector)

Rx

Adenovirus type 5 vector based ebola virus disease vaccine

Ebola Zaire vaccine (live, attenuated)(Zabdeno)

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

AIM ImmunoTech Positions Ampligen as Potential Ebola Treatment Following WHO Emergency Declaration

RedHill Biopharma Advances Opaganib for Bundibugyo Ebola Outbreak as Cases Surpass 3,200

UK Humanitarian Worker Under Ebola Monitoring in London Following Potential Exposure in DRC